Seoul, 10:18 pm Wednesday, 26 February 2025 (GMT+9) – South Korea’s stock market experienced sharp declines in several stocks today, with Cellivery Therapeutics, Inc. leading the losses, plunging 40.56% to close at 85 KRW. The sharp drop reflects strong selling pressure and investor uncertainty.
BL Pharmtech also faced a steep decline, falling 29.99% to 1,445 KRW, while Medience Co., Ltd. lost 20.12%, closing at 2,620 KRW. Kainos Medicine, Inc. and NSM both saw significant drops of 15.91% and 15.00%, respectively. G&E Healthcare also declined 15.00%, closing at 663 KRW.
The losses indicate heightened market volatility, with some stocks facing strong corrections. Investors remain cautious as external economic factors and company-specific issues impact market sentiment.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Stock market investments are subject to risks, and past performance does not guarantee future results.